Insider · CIK 0001743173
Lilian Shackelford Murray
Files at RKDA (Arcadia Biosciences, Inc.). First filing -, latest -.
In brief
Lilian Shackelford Murray files SEC Form 4 as director at RKDA (Arcadia Biosciences, Inc.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Lilian Shackelford Murray has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 1 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Sep 10, 2026 | RKDA Arcadia Biosciences, Inc. | AGrant or award Stock Option (Right to Buy)derivative | +10,000 | $0.00 | $0 | 23,287 | 30 d ago |
Questions about Lilian Shackelford Murray
Answered from the filings on this page, as of the latest one.
Is Lilian Shackelford Murray buying or selling?
Lilian Shackelford Murray has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Lilian Shackelford Murray's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Lilian Shackelford Murray has 0.
Where does Lilian Shackelford Murray file Form 4?
Lilian Shackelford Murray has filed Form 4 at RKDA (Arcadia Biosciences, Inc.). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.